Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 05-Sep 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 75618501000001111 | Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 75618601000001110 | Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) | Is a | Carbidopa + levodopa 25mg/100mg m/r tablet | false | Inferred relationship | Existential restriction modifier | ||
| Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) | Has active ingredient | Carbidopa | false | Inferred relationship | Existential restriction modifier | ||
| Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) | Has active ingredient | Levodopa | false | Inferred relationship | Existential restriction modifier | ||
| Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) | Has manufactured dose form | Modified-release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) | Has specific active ingredient | Levodopa | false | Inferred relationship | Existential restriction modifier | ||
| Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) | Has specific active ingredient | Carbidopa monohydrate | false | Inferred relationship | Existential restriction modifier | ||
| Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) | Has dispensed dose form | Modified-release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Carbidopa | false | Inferred relationship | Existential restriction modifier | ||
| Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) | Has excipient | Excipient not declared | false | Inferred relationship | Existential restriction modifier | ||
| Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) | Is a | Actual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
| Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) | Has specific active ingredient | Carbidopa monohydrate | false | Inferred relationship | Existential restriction modifier | ||
| Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) | Has basis of strength substance | Carbidopa | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) 60 tablet | Has AMP | False | Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR